Insulinoma-Associated Protein 1 (INSM1) is emerging as a significant marker in the diagnosis and characterization of neuroendocrine tumors (NETs). These tumors arise from neuroendocrine cells ...

M: Metastasis; N: Node; T: Tumor. Data from [21]. Neuroendocrine tumors have demonstrated an increase in incidence and prevalence over the past decades, partly due to increased awareness ...

In the United States (US), the estimated annual incidence of neuroendocrine tumors is approximately 7 cases per 100,000 individuals. 3,4 Overall, more than 170,000 people are living with ...

This combination has “the potential to become a new standard first-line treatment” for well-differentiated grade 1/2 gastroenteropancreatic neuroendocrine tumors with poor prognostic factors ...

Comparative outcomes of neuroendocrine tumors in the historically underserved population of Bronx, NY: Montefiore Einstein Comprehensive Cancer Center. Pamrevlumab ...

On second thought, the FDA figures it no longer needs to discuss Exelixis’ application for Cabometyx in neuroendocrine tumors at an advisory committee meeting. Exelixis disclosed the ...

Effect of marital status and race on survival of patients with well differentiated neuroendocrine tumors (NETs). Clinicopathological factors related to survival in gastroenteropancreatic ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Join the conversation with Fred Hutch Cancer Center. Enhance your knowledge and skills in the treatment of neuroendocrine tumors at our upcoming virtual event. Hosted by renowned experts Delphine Chen ...

One example of this occurs when a person has a pancreatic neuroendocrine tumor. This growth releases hormones that ... indicating the need to investigate further. When a person has cancer, their ...

Imaging, including transvaginal ultrasound or non-invasive abdominal imaging may reveal the tumor. A biopsy is the method of definitive diagnosis. Cancer markers like CA-125, HE4, and CA-19-9 might be ...